Jacobs Levy Equity Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-100,172
Closed -$932K 938
2024
Q3
$932K Sell
100,172
-75,737
-43% -$704K ﹤0.01% 732
2024
Q2
$1.64M Buy
+175,909
New +$1.64M 0.01% 640
2023
Q1
Sell
-190,818
Closed -$2.82M 957
2022
Q4
$2.82M Sell
190,818
-41,395
-18% -$613K 0.02% 490
2022
Q3
$4.44M Buy
+232,213
New +$4.44M 0.04% 418